Analyst Ratings for Dimension Therapeutics (DMTX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.9 / 10
Percentile Rank: 24%
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/3/2017 | Wells Fargo | N/A | Downgrade | Equal Weight (Overweight) |
6.00 (N/A) |
5.90 (5.95) |
0.85% | Details |
| 10/3/2017 | Citi | N/A | Upgrade | Neutral (Sell) |
6.00 (5.50) |
5.90 (5.95) |
0.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
